Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Lipasin (also known as C19ORF80, RIFL, ANGPTL8 and betatrophin) is a newly discovered circulating factor that regulates lipid metabolism and promotes pancreatic β-cell proliferation. Whether circulating levels of lipasin in humans are altered in a) type 2 diabetes; b) obesity and c) the postprandial state, however, is unknown. The current study aimed to compare serum lipasin levels in those who were a) non-diabetic (N=15) or diabetic (BMI- and age-matched; N=14); b) lean or obese (N=53 totally) and c) fasting and 2 hours following a defined meal (N=12). Serum lipasin levels were determined by the enzyme-linked immunosorbent assay. Lipasin levels [mean±SEM] were increased by more than two fold (P<0.001) in the diabetic patients (5.56±0.73 ng/mL) as compared to the control subjects (2.19±0.24 ng/mL). Serum lipasin levels were positively correlated with BMI (rho=0.49, P<0.001), and showed a 35% increase 2 hours following a defined meal (P=0.009). Therefore, lipasin/betatrophin is nutritionally-regulated hepatokine that is increased in human type 2 diabetes and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This is substantiated by the fact that betatrophin levels are higher in T2DM patients,182, 183, 184 although they were lower in one study.185”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
RetractedEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Uyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 529
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Cited by
Items 201–230 of 230
Alenazi, M. M., Sabico, S., Alnaami, A. M., Wani, K., Hussain, S. D., & Al‐Daghri, N. M. (2024) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2024.103469 · Cited by 1
Odyjewska, E., Kupińska, M., Jamiołkowska‐Sztabkowska, M., Bossowski, A. T., & Głowińska‐Olszewska, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1602777 · Cited by 2
“Studies have shown that betatrophin levels are also elevated in T2D patients and may be in fl uenced by the duration of the disease (25, 34 – 36).”
Negro, E. M., Fernández‐García, P., Martín-Taboada, M., Soria‐Gondek, A., Marín, D. R., Pérez, P. C., Cortijo, S. M., Antolinez, M. A., Mora-Jiménez, I., Martínez, L., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70141 · Cited by 1
“This phenomenon could be key in preparing the sWAT for a transition to a metabolically healthier state, contributing to long-term metabolic improvements with obesity after BS.”
Serum Betatrophin: What It Shows and How It Alters in Gestational Diabetes Mellitus
Melekoğlu, R., & Çelik, E. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_19 · Cited by 1
Arıkan, F. B., Ulaş, M., Üstündağ, Y., Boyunağa, H., & Badem, N. D. (2023) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2022-0104 · Cited by 2
Susanto, H., Aulanni’am, A., Wuragil, D. K., Taufiq, A., Sunaryono, S., Purnomo, J. D. T., Krisnawati, D. I., & Sholeh, M. (2025) · INDONESIAN JOURNAL OF MEDICAL LABORATORY SCIENCE AND TECHNOLOGY · doi:10.33086/ijmlst.v7i1.6028 · Cited by 1
“Elevated levels of this liver-derived hormone have been confirmed in individuals with hypertriglyceridemia (14,15), metabolic syndrome in young women (16), obesity (17 – 19), new-onset diabetes (20), nephropathy (21), and pancreatic cancer patients with diabetes (22).”
Mohammed, A. K., & Khazaal, F. A. K. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20163119 · Cited by 1
Assessment of circulating betatrophin levels in intrahepatic cholestasis of pregnancy
Kara, Ö., Kırbaş, A., Yakut, K., Dağlar, K., Tımur, H., İnal, Z. Ö., & Üstün, Y. E. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1481382 · Cited by 1
“Inconsistent results have been reported regarding the correlation of betatrophin levels with obesity and Type 2DM; both increased [32] and decreased [33] levels have been reported.”
ResultBiomarkers of Insulin Resistance
Cox‐York, K. A., & Pereira, R. I. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_11 · Cited by 1
Siddiqa, A., Ahmad, J., Ali, A., & Khan, S. (2019) · IET Systems Biology · doi:10.1049/iet-syb.2019.0032 · Cited by 1
“(2014) reported the presence of a ChREBP binding site (−398 to −382) in the promoter region of ANGPTL8 gene [36].”
BackgroundSerum Betatrophin: What It Shows and How It Alters in Gestational Diabetes Mellitus
Melekoğlu, R., & Çelik, E. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_19-1 · Cited by 1
(2023) · Journal of Gastroenterology & Digestive Systems · doi:10.33140/jgds.07.01.04 · Cited by 1
Mohammedsaeed, W. M., & Binjawhar, D. N. (2024) · Diabetes and Vascular Disease Research · doi:10.1177/14791641241259792 · Cited by 1
Stéatose et résistance à l’insuline : implication des hépatokines
Bertrand, C., Valet, P., & Castan‐Laurell, I. (2015) · Obésité · doi:10.1007/s11690-015-0492-7
Cirillo (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190118ec
Susanto, H., Listyorini, D. I., Taufiq, A., Kharisma, V. D., Handaya, A. Y., Pertiwi, M. P., Nisa, S. A. R., & Khasna, E. N. (2019) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/515/1/012094
Saremi, A., Bayat, M., Sadegh, M., & Amri, J. (2019) · The Journal of Qazvin University of Medical Sciences · doi:10.32598/jqums.23.3.202
“Lipases, also known as angiopoietin-like protein, is a newly identified circulating protein predominantly produced in the liver and adipose tissue [3-6].”
BackgroundGEHAD A.A. GOMA, M. S. H. A. E.-S., & El-Nagar, M. (2019) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2019.52331
Susanto, H., Liou, N.-S., Pratomo, B., Hernowati, T. E., Handaya, A. Y., Susianti, H., Budianto, M. B., Gofur, A., Norahmawati, E., & Ariani, N. L. (2020) · AIP conference proceedings · doi:10.1063/5.0002469
Gong, W. J., Bilixzi, A., Wang, X., Lu, Y., Wan, L., & Han, L. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01198-4
Common indications of permanent pacemaker insertion.
Ahmed, S. M., & Ansari, M. J. (2008) · PubMed
Study of serum betatrophin level as a biochemical marker in patients with type 2 diabetes mellitus
Abbas, N., ABOUELMAGD, M. M., Marzouk, H. F. A., & Elghaba, M. (2022) · International Journal of Medical Arts · doi:10.21608/ijma.2022.99440.1377
Mubasyiroh, N. A., Sugiharto, S., Merawati, D., Fathil, N. E. F. M., Rejeki, P. S., Widyatama, F. S., & Pranoto, A. (2024) · JOSSAE (Journal of Sport Science and Education) · doi:10.26740/jossae.v9n1.p1-7
“Improved glucose absorption, which is transformed into energy, will lower blood glucose levels and betatrophin release (Fu et al., 2014).”
BackgroundInfluentialDu, C., Wang, N., Ma, X., Feng, Y., Liu, F., Deng, Y., Xie, X., & Zhang, Y. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2530568
“ANGPTL8, also known as Betatrophin, is a newly identified biomarker associated with glycolipid metabolism and ovarian reserve function [27,28].”
原田, 万. (2023) · Institutional Repositories DataBase (IRDB)
Inter-organ communication in physiology and pathophysiology : a role for the ChREBP-FGF21 axis?
Carbinatti, T. (2024) · theses.fr (ABES) · doi:10.70675/5d147ab4zad37z4f6bzac51z32a08efeaa51
Extracellular vesicles in the diagnosis of diabetes mellitus and associated complications
Mourya, A. K., Jain, R., & Kumar, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36641-3.00001-2
Tanrıverdi, M. D. E., & Tokmak, A. (2026) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2026.05.010
Elevated betatrophin influences cardiometabolic risk factors in adolescents
Alzamil, H. A., Al-Masri, A. A., Al-Ghannam, F. A. A., Alamro, A. A., Alghamdi, A. S., Wani, K., Sabico, S., & Al‐Daghri, N. M. (2026) · Journal of King Saud University - Science · doi:10.25259/jksus_1084_2025
Metadata
- Authors
- Fu, Z., Berhane, F., Fite, A., Seyoum, B., Abou-Samra, A. B., & Zhang, R.
- Affiliations
- Wayne State University (US)
- Corresponding author
- Zhang, Ren
- Venue
- Scientific Reports
- Published
- 2014-05-23
- Volume
- 4
- Issue
- 1
- Pages
- 5013-5013
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5381405
- OpenAlex
- W2154364167
- Cited by
- 232
- References
- 22
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 13 · 2022: 16 · 2021: 17 · 2020: 25 · 2019: 18 · 2018: 22 · 2017: 31 · 2016: 32 · 2015: 24 · 2014: 7
- FWCI
- 23.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Wayne State University (176412)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- betatrophin, type 2 diabetes, obesity, hepatokines, postprandial lipemia, body mass index, pancreatic beta-cell proliferation, lipid metabolism, serum biomarkers
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Prognosis, Biomarkers, Case-Control Studies, Peptide Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.